about
Independent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IA.Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial.Low specificity and sensitivity of smell identification testing for the diagnosis of Parkinson's disease.Clinical determinants of health-related quality of life in Mexican patients with Parkinson's disease.Comparing the accuracy of different smell identification tests in Parkinson's disease: relevance of cultural aspects.Apathy and associated factors in Mexican patients with Parkinson's disease.Factors associated with the quality of life of subjects with Parkinson's disease and burden on their caregivers.Impulse control and related disorders in Mexican Parkinson's disease patients.Relationship between the type and side of motor symptoms with the prevalence of non-motor symptoms in Parkinson's disease.Prevalence and determinants of depression in Mexican patients with Parkinson's disease.A reappraisal of the ten steps test for identifying atypical parkinsonism.Caffeine drinking, cigarette smoking, and dopaminergic replacement therapy dose in Parkinson's disease.A prospective series of patients with hyperglycaemia-associated movement disorders.Opsoclonus Myoclonus Syndrome associated with GQ1b AntibodiesClinical, imaging, and molecular findings in a sample of Mexican families with pantothenate kinase-associated neurodegenerationRespuesta ortostática de la tensión arterial de pacientes con enfermedad de Parkinson inicialOverweight is more prevalent in patients with Parkinson's diseaseUse of smell test identification in Parkinson's disease in Mexico: A matched case-control studyAssociation Between Somatization and Nonmotor Symptoms Severity in People With Parkinson DiseaseFalls in persons with Parkinson's disease: Do non-motor symptoms matter as much as motor symptoms?
P50
Q34481209-74543C3B-1B43-40BF-8423-D2C82D90412BQ37276142-0CB4DB3A-60BE-4733-B9C1-562CAD2763B7Q45358322-F70641CD-C494-4BDA-966C-D7F9676E9D2BQ45697484-8035517D-C094-4C65-886C-6C4799D3AFC0Q47625425-87E67233-060D-41FB-8791-6EF53E226722Q47948376-D11D8F5E-F760-471B-817C-5D1981EF0B52Q48080818-A33F611E-A233-490F-A79E-8D54F68C86A6Q48272332-1880EA3C-92B7-49D0-82ED-4A369220013DQ48317265-1A718A4D-4C5D-458D-90B7-9CB92734EDB1Q48697786-2F28B41A-F9BB-4345-9375-849DCB9EDE13Q50476590-E5D95B60-0E83-4E96-85FB-D03E5E163AE8Q50913570-6CE3BDC1-5580-4190-B900-F95E17625D1AQ51370410-4D097681-373B-408E-953B-1B54E064761AQ60049838-C6A5C315-5546-42DE-8F30-AD778098B761Q61882769-22F6A175-A56D-40B0-BBB4-3893DE5D3848Q61882826-D09ECD8C-611B-4C26-B75A-29889EF13B3FQ61882843-BC857C59-6143-4CEF-AE62-898FFAE619F6Q61882855-C7AECA5C-8A65-4340-ADDE-8A3FA0F68D0AQ89572163-D0BED517-8EAB-4BA0-8843-29C4F3E6DD28Q91880484-6854D611-1089-4839-9B47-DFF91CD78DF5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Amin Cervantes-Arriaga
@ast
Amin Cervantes-Arriaga
@en
Amin Cervantes-Arriaga
@es
Amin Cervantes-Arriaga
@nl
Amin Cervantes-Arriaga
@sl
type
label
Amin Cervantes-Arriaga
@ast
Amin Cervantes-Arriaga
@en
Amin Cervantes-Arriaga
@es
Amin Cervantes-Arriaga
@nl
Amin Cervantes-Arriaga
@sl
prefLabel
Amin Cervantes-Arriaga
@ast
Amin Cervantes-Arriaga
@en
Amin Cervantes-Arriaga
@es
Amin Cervantes-Arriaga
@nl
Amin Cervantes-Arriaga
@sl
P106
P1153
56013660300
P21
P31
P496
0000-0002-3935-9278